Explore the vast range of titles available.

High hydrogen absorption and desorption rates are two significant index parameters for the applications of hydrogen storage tanks. The analysis of the hydrogen absorption and desorption behavior using the isothermal kinetic models is an efficient way to investigate the kinetic mechanism. Multitudinous kinetic models have been developed to describe the kinetic process. However, these kinetic models were deduced based on some assumptions and only appropriate for specific kinetic measurement methods and rate-controlling steps (RCSs), which sometimes lead to confusion during application. The kinetic analysis procedures using these kinetic models, as well as the key kinetic parameters, are unclear for many researchers who are unfamiliar with this field. These problems will prevent the kinetic models and their analysis methods from revealing the kinetic mechanism of hydrogen storage alloys. Thus, this review mainly focuses on the summarization of kinetic models based on different kinetic measurement methods and RCSs for the chemisorption, surface penetration, diffusion of hydrogen, nucleation and growth, and chemical reaction processes. The analysis procedures of kinetic experimental data are expounded, as well as the effects of temperature, hydrogen pressure, and particle radius. The applications of the kinetic models for different hydrogen storage alloys are also introduced.

Increasing evidence has indicated that long noncoding RNAs (lncRNAs) are of great importance in different cell contexts. However, only a very small number of lncRNAs have been experimentally validated and functionally annotated during human hematopoiesis. Here, we report an lncRNA, HOTAIRM1, which is associated with myeloid differentiation and has pivotal roles in the degradation of oncoprotein PML-RARA and in myeloid cell differentiation by regulating autophagy pathways. We first revealed that HOTAIRM1 has different variants that are expressed at different levels in cells and that the expression pattern of HOTAIRM1 is closely related to that of the PML-RARA oncoprotein in acute promyelocytic leukemia (APL) patients. We further revealed that the downregulation of HOTAIRM1 could inhibit all-trans retinoic acid (ATRA) -induced degradation of PML-RARA in APL cells and repress the process of differentiation from promyelocytic to granulocytic cells. More importantly, we found that HOTAIRM1 regulates autophagy and that autophagosome formation was inhibited when HOTAIRM1 expression was reduced in the cells. Finally, through the use of a dual luciferase activity assay, AGO2 RNA immunoprecipitation and RNA pull-down, HOTAIRM1 was revealed to act as a microRNA sponge in a pathway that included miR-20a/106b, miR-125b and their targets ULK1, E2F1 and DRAM2. We constructed a human APL-ascites SCID mouse model to validate the function of HOTAIRM1 and its regulatory pathway in vivo . This is the first report showing that a lncRNAs regulates autophagy and the degradation of the PML-RARA oncoprotein during the process of myeloid cell differentiation blockade, suggesting that lncRNAs may be the potential therapeutic targets for leukemia.

The combination of bioaugmentation and biostimulation was used to speed up the bioremediation of marine oil spills. A novel carrier material that consisted of puffed panicum miliaceum (PPM), calcium alginate and chitosan was prepared. The porous structure and low density of PPM ensured this carrier material not only had appropriate physical and biological properties for the aggregation of microorganisms but also was biodegradable and floating on the seawater surface for bioremediation of oil pollution. An oil-degrading bacterial consortium was immobilized via adsorption on the carrier material. The immobilized bacteria were observed with scanning electron microscopy. The number of viable cells immobilized on the material was approximately 1.12 × 108 CFU/g. To solve the problem of nutrients supplementation in seawater, an emulsion formed with urea solution, soybean lecithin, alcohol and oleic acid was prepared as oleophilic fertilizer. The results from laboratory and field mesocosm experiments showed that the combination of immobilized bacteria and the emulsion achieved a higher oil removal efficiency compared with the use of them separately. The results of field mesocosm experiments conducted in the coastal seawater showed that most of the petroleum pollutant (> 98%) was removed from the surface of seawater in 24 h. GC–MS analysis showed that most components of petroleum pollutants had been removed. This formula with immobilized bacteria and emulsion can be exploited further for the bioremediation of marine oil spills.

Acute kidney injury (AKI) is frequent among in-hospital patients with high incidence and mortality. Implementing a series of evidence-based AKI care bundles may improve patient outcomes by reducing changeable standards of care. The aim of this meta-analysis was therefore to appraise the influences of AKI care bundles on patient outcomes. We explored three international databases (PubMed, Embase, and Cochrane Central Register of Controlled Trials) and two Chinese databases (Wanfang Data and China National Knowledge Infrastructure) for studies from databases inception until November 30, 2022, comparing the impact of different AKI care bundles with usual standards of care in patients with or at risk for AKI. The study quality of non-randomized controlled trials and randomized controlled trials was evaluated by the NIH Study Quality Assessment Tool and the Cochrane risk of bias tool. Heterogeneity between studies was appraised by Cochran's Q test and I2 statistics. The possible origins of heterogeneity between studies were assessed adopting Meta-regression and subgroup analyses. Funnel plot asymmetry and Egger regression and Begg correlation tests were performed to discover potential publication bias. Data analysis was completed by software (RevMan 5.3 and Stata 15.0). The primary outcome was short- or long-term mortality. The secondary outcomes involved the incidence and severity of AKI. Sixteen studies containing 25,690 patients and 25,903 AKI episodes were included. In high-risk AKI patients determined by novel biomarkers, electronic alert or risk prediction score, the application of AKI care bundles significantly reduced the AKI incidence (OR, 0.71; 95% CI, 0.53-0.96; p = 0.02; I2 = 84%) and AKI severity (OR, 0.59; 95% CI, 0.39-0.89; p = 0.01; I2 = 65%). No strong evidence is available to prove that care bundles can significantly reduce mortality (OR, 1.16; 95% CI, 0.58-2.30; p = 0.68; I2 = 97%). The introduction of AKI care bundles in routine clinical practice can effectively improve the outcomes of patients with or at-risk of AKI. However, the accumulated evidence is limited and not strong enough to make definite conclusions.

Compared to conventional (p-i-n) organic photovoltaics (OPVs), inverted (n-i-p) OPVs hold promise for future commercial applications due to their advantages in printing process compatibility and environment robustness. The current bottleneck lies in the efficiency and light stability, which is closely related to the defects and the photocatalytic reactivity of metal oxides transport layer. This comment summarizes the recent progress on inverted OPV and outlines potential solutions to surmount the hurdles before the technology can be put into production. The efficiency and light stability of inverted organic photovoltaics have been limited by the defects and photocatalytic reactivity of metal oxides transport layer. Here, authors discuss the recent progress and potential solutions for this technology to be put into production and industrialization.

The long noncoding RNA ANRIL has been found to be abnormally expressed and play important roles in different cancers. However, the expression and function of ANRIL in acute myeloid leukemia (AML) remain to be declared. In this study, we found that ANRIL is up-regulated in AML patients at diagnosis and down-regulated in patients after complete remission (CR). Functional studies showed that knockdown of ANRIL expression resulted in a decline in glucose uptake and inhibition of AML cell maintenance in vitro and in vivo. Mechanically, ANRIL was found to repress the expression of Adiponectin receptor (AdipoR1), a key regulator of glucose metabolism. Both ANRIL and AdipoR1 knockdown reduced the expression levels of phosphorylation of AMPK and SIRT1, implying a previously unappreciated ANRIL-AdipoR1-AMPK/SIRT1 signaling pathway in regulating cell glucose metabolism and survival in AML. The study is the first to demonstrate that ANRIL promotes malignant cell survival and cell glucose metabolism to accelerate AML progression and is a potential prognostic marker and therapeutic target in AML treatment.

Data in terms of how active vitamin D supplementation affects muscle mass and function in end-stage renal disease (ESRD) patients has led to inconclusive results. The main goal of this research was to examine the association of active vitamin D supplementation and risk of the deterioration of muscle mass and function among ESRD patients on peritoneal dialysis (PD). Eligible ESRD patients on PD were prospectively included, and followed up at 3-month intervals in the tertiary care center. Based on the medications during the 12-month follow-up period, the patients were divided into two groups (vitamin D users and non-users). The deterioration of muscle mass and function was identified utilizing the criteria set by the Asian Working Group on Sarcopenia in 2019 (AWGS 2019). Primary outcome was defined as the deterioration of muscle mass and function at the end of the 12-month follow-up. The absolute diffecence and 95% confidence interval (CI) of the incidence of deterioration between vitamin D users and non-users was estimated. The association of vitamin D supplementation with risk of the deterioration of muscle mass and function during the 12-month follow-up period, was examined by employing multivariate logistic regression models. A total of 229 incident PD patients (6 of whom were lost in follow-up) were included. During the entire study period, 54.7% (122/223) of the remaining patients were considered users of oral active vitamin D. The incidence of deterioration in muscle mass and function was 30.5% (68/223) throughout the entire follow-up. In this regard, the rate was 23.0% (28/122) that received oral active vitamin D, while it was 39.6% (40/101) in the group that did not receive it, with an absolute diffecence of -16.6% (95% CI − 4.5, − 28.7) and an estimated relative risk (RR) of 0.784 (95% CI 0.651–0.943). After adjustment for potential confounding factors in logistic regression model, vitamin D users group was still associated with decreased risk of the deterioration of muscle mass and function (OR 0.330, 95% CI 0.159–0.683, P  = 0.003). In secondary analysis, the relationship between oral active vitamin D and the deterioration of muscle mass and function remained consistent (≤ 0.25 µg per day vs. non-users; OR 0.300, 95% CI 0.131–0.688, P  = 0.004); however, no significant relationship was identified in patients receiving a mean daily dose of > 0.25 µg compared with non-users (OR 0.389, 95% CI 0.146–1.034, P  = 0.058). These results indicate that active vitamin D supplementation was significantly associated with a decreased risk of the deterioration of muscle mass and function in incident PD patients with ESRD. However, the amount and type of vitamin D used and the duration of the intervention warrant further randomized controlled trials to confirm the possibility that such medication improves sarcopenia in ESRD patients.

Organic solar cells (OSCs) have gained a rapid development in the past two decades and the power conversion efficiency (PCE) of single-junction OSC has recently approached 20%. The novel materials and device engineering are two key factors of this evolution. In this review, the device engineering, including morphology characterization and optimization, device physics, flexible and large-area OSCs, and stability of OSCs are systematically summarized. In addition, the current challenges, problems and future developments are also discussed.

Chronic kidney disease (CKD) represents a growing global health burden, with an increasing number of CKD patients progressing to renal failure or end-stage renal disease (ESRD). Hemodialysis is widely regarded as the usual treatment modality for patients with ESRD. Currently, more than 85% of patients initiating hemodialysis (HD) in the United States utilize a catheter for vascular access. HD is often inseparable from the use of catheters in clinical practice. Consequently, the utilization of HD catheters has risen, despite their associated complications and adverse outcomes. To minimize complications during dialysis sessions, various strategies are employed, including optimized catheter designs, specialized catheter lock solutions or functional coatings, and effective catheter care. This review outlined the current state and development of HD catheters, along with the associated adverse outcomes and effective care strategies.

Background IgA nephropathy(IgAN)) is the common pathological type of glomerular diseases. The role of gut microbiota in mediating “gut-IgA nephropathy” has not received sufficient attention in the previous studies. The purpose of this study was to investigate the changes of fecal short-chain fatty acids(SCFAs), a metabolite of the intestinal microbiota, in patients with IgAN and its correlation with intestinal flora and clinical indicators, and to further investigate the role of the gut-renal axis in IgAN. Methods There were 29 patients with IgAN and 29 normal control subjects recruited from January 2018 to May 2018. The fresh feces were collected. The fecal SCFAs were measured by gas chromatography/mass spectrometry and gut microbiota was analysed by16S rDNA sequences, followed by estimation of α- and β-diversity. Correlation analysis was performed using the spearman’s correlation test between SCFAs and gut microbiota. Results The levels of acetic acid, propionic acid, butyric acid, isobutyric acid and caproic acid in the IgAN patients were significantly reduced compared with control group( P  < 0.05). Butyric acid(r=-0.336, P  = 0.010) and isobutyric acid(r=-0.298, P  = 0.022) were negatively correlated with urea acid; butyric acid(r=-0.316, P  = 0.016) was negatively correlated with urea nitrogen; caproic acid(r=-0.415, P  = 0.025) showed negative correlation with 24-h urine protein level.Exemplified by the results of α-diversity and β-diversity, the intestinal flora of IgAN patients was significantly different from that of the control group. Acetic acid was positively associated with c_Clostridia (r = 0.357, P  = 0.008), o_Clostridiales (r = 0.357, P  = 0.008) and g_Eubacterium_coprostanoligenes_group (r = 0.283, P  = 0.036). Butyric acid was positively associated with g_Alistipes (r = 0.278, P  = 0.040). The relative abundance of those were significantly decreased in IgAN group compared to control group. Conclusions The levels of fecal SCFAs in the IgAN patients were reduced, and correlated with clinical parameters and gut microbiota, which may be involved in the pathogenesis of IgAN, and this finding may provide a new therapeutic approach.